Tamoxifen Alters the Plasma Concentration of Molecules Associated with Cardiovascular Risk in Women with Breast Cancer Undergoing Chemotherapy

OBJECTIVES. The objective of this study was to evaluate the effect of tamoxifen on blood markers that are associated with cardiovascular risk, such as C-reactive protein (CRP), apolipoprotein A-1 (Apo-A), and apolipoprotein B-100 (Apo-B), in women undergoing chemotherapy for breast cancer. METHODS....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Romero, Walckiria G., Da Silva, Fabrício B., Borgo, Mariana V., Bissoli, Nazaré S., Gouvêa, Sonia A., Abreu, Gláucia R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2012
Gaiak:
Breast Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3336829/
https://ncbi.nlm.nih.gov/pubmed/22491005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0369
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak